Avita Medical’s Insider Surge: Founder Buys 20,000 Shares as Top Execs Ramp Up Confidence Ahead of Q1 Results
Avita Medical insider buying surge signals management confidence in its clinical pipeline, yet stock remains volatile; investors should track upcoming data and regulatory filings.
3 minutes to read
